ConductScience.org, home

Paper10073734

The use of atypical antipsychotics in the management of schizophrenia.

Campbell M and 4 others. Br J Clin Pharmacol, 1999. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. The use of atypical antipsychotics in the management of schizophrenia. Papers, record 10073734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073734

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The use of atypical antipsychotics in the management of schizophrenia.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1999
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2023-11-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Campbell MM
2Young PIP I
3Bateman DND N
4Smith JMJ M
5Thomas SHS H

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
SchizophreniaMajor topic
Basal Ganglia Diseases
Clinical Trials as Topic
Cost-Benefit Analysis
Humans
Mood Disorders

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17537287Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.J Clin Psychopharmacol1995https://conductscience.org/library/papers/7537287PubMed
29337946Cost-effectiveness of clozapine. A UK clinic-based study.Br J Psychiatry1997https://conductscience.org/library/papers/9337946PubMed
39298518Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.Psychopharmacology (Berl)1997https://conductscience.org/library/papers/9298518PubMed
47494570Schizophrenia.N Engl J Med1996https://conductscience.org/library/papers/7494570PubMed
57523815Risperidone-induced neuroleptic malignant syndrome.Lancet1994https://conductscience.org/library/papers/7523815PubMed
68611817Treatment resistance in schizophrenia.BMJ1996https://conductscience.org/library/papers/8611817PubMed
72282615An update on the epidemiology of schizophrenia.Can J Psychiatry1990https://conductscience.org/library/papers/2282615PubMed
88822534Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.Neuropsychopharmacology1996https://conductscience.org/library/papers/8822534PubMed
99270900Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.Biol Psychiatry1997https://conductscience.org/library/papers/9270900PubMed
109117479Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.Psychiatr Serv1996https://conductscience.org/library/papers/9117479PubMed
118935813A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8935813PubMed
128094781Schizophrenia: developmental neuroscience and pathobiology.Lancet1993https://conductscience.org/library/papers/8094781PubMed
139315992Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol1997https://conductscience.org/library/papers/9315992PubMed
148425137Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.Br J Psychiatry1993https://conductscience.org/library/papers/8425137PubMed
158610833Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study.Am J Psychiatry1996https://conductscience.org/library/papers/8610833PubMed
169241010Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol.J Clin Psychopharmacol1997https://conductscience.org/library/papers/9241010PubMed
178515788Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.N Engl J Med1993https://conductscience.org/library/papers/8515788PubMed
1810172917Measuring quality of life in patients with schizophrenia.Pharmacoeconomics1997https://conductscience.org/library/papers/10172917PubMed
199350955A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.Acta Psychiatr Scand1997https://conductscience.org/library/papers/9350955PubMed
209169300Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.Eur Neuropsychopharmacol1997https://conductscience.org/library/papers/9169300PubMed

See all 25 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
40161932Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia.Bioimpacts2025https://conductscience.org/library/papers/40161932PubMed
36895943Vitamin D supplementation is effective for olanzapine-induced dyslipidemia.Front Pharmacol2023https://conductscience.org/library/papers/36895943PubMed
34491479Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine.Metab Brain Dis2021https://conductscience.org/library/papers/34491479PubMed
33580033One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia.NPJ Schizophr2021https://conductscience.org/library/papers/33580033PubMed
28701621Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models.Exp Anim2017https://conductscience.org/library/papers/28701621PubMed
28088913A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia.Curr Neuropharmacol2017https://conductscience.org/library/papers/28088913PubMed
26599405Asenapine versus placebo for schizophrenia.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26599405PubMed
22558126Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.PLoS One2012https://conductscience.org/library/papers/22558126PubMed
17876506Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.Eur Child Adolesc Psychiatry2008https://conductscience.org/library/papers/17876506PubMed
15649104Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.Drug Saf2005https://conductscience.org/library/papers/15649104PubMed
14728058Long-acting risperidone: a review of its use in schizophrenia.CNS Drugs2004https://conductscience.org/library/papers/14728058PubMed
14720078Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.Pharmacoeconomics2004https://conductscience.org/library/papers/14720078PubMed
12383035Aripiprazole.CNS Drugs2002https://conductscience.org/library/papers/12383035PubMed
10843459Biotransformation of post-clozapine antipsychotics: pharmacological implications.Clin Pharmacokinet2000https://conductscience.org/library/papers/10843459PubMed
10740987Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.J Psychiatry Neurosci2000https://conductscience.org/library/papers/10740987PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10073734

GET https://conductscience.org/api/papers/v1/10073734/references?page=2